Rho GTPases, which control processes such as cell proliferation and cytoskeleton remodeling, are often hyperexpressed in tumors. Several members, such as RhoA/B/C, must be isoprenylated to interact with their effectors. Statins, by inhibiting the synthesis of prenyl groups, may affect RhoA/B/C activity and represent a promising tool in anticancer therapy.

Rho-GTPases and Statins: A Potential Target and a Potential Therapeutic Tool Against Tumors?

CAMPIA, IVANA;DOUBLIER, Sophie Michelle;ALDIERI, Elisabetta;BOSIA, Amalia;GHIGO, Dario Antonio;RIGANTI, Chiara
2014-01-01

Abstract

Rho GTPases, which control processes such as cell proliferation and cytoskeleton remodeling, are often hyperexpressed in tumors. Several members, such as RhoA/B/C, must be isoprenylated to interact with their effectors. Statins, by inhibiting the synthesis of prenyl groups, may affect RhoA/B/C activity and represent a promising tool in anticancer therapy.
2014
Recent Advances in Medicinal Chemistry
Bentham Sciences Publisher
1
209
245
I. Campia; S. Doublier; E. Aldieri; A. Bosia; D. Ghigo; C. Riganti
File in questo prodotto:
File Dimensione Formato  
Campia, ebook Bentham, 2014.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 582.21 kB
Formato Adobe PDF
582.21 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Campia_Bentham ebook_post print 2014.pdf

Open Access dal 02/01/2016

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 750.41 kB
Formato Adobe PDF
750.41 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/136793
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact